Download by
Scanning QR Code
CN Stock MarketDetailed Quotes
000963 Huadong Medicine
Watchlist
40.05
-0.24-0.60%
Market Closed 09/22 15:00 CST
40.50High39.50Low125.85KlotVolume
40.49Open40.29Pre Close502.09MTurnover0.72%Turnover Ratio27.10P/E (TTM)70.25BMarket Cap51.6252wk High28.11P/E (Static)1.75BShares36.4352wk Low3.60P/B70.08BFloat Cap53.13Historical High44.32Limit Up1.75BShs Float-2.45Historical Low36.26Limit Down2.48%Amplitude57.46KlotAsk0.29Dividend TTM39.89Avg Price61.86KlotBid0.72%Div YieldTTM100Lot Size
Huadong Medicine Key Stats
All
YOY

(Q6)2023/06/30 | (Q3)2023/03/31 | (FY)2022/12/31 | (Q9)2022/09/30 | (Q6)2022/06/30 | (Q3)2022/03/31 | (FY)2021/12/31 | (Q9)2021/09/30 | (Q6)2021/06/30 | (Q3)2021/03/31 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | 19.37%22.51B | 22.33%9.96B | 5.95%39.95B | 3.47%28.64B | -2.08%18.86B | -7.03%8.14B | 4.12%37.71B | 4.99%27.67B | 11.30%19.26B | 14.23%8.76B |
Refunds of taxes and levies | 14.86%13.11M | -70.23%1.21M | -15.08%47.56M | 313.13%48.13M | 512.73%11.41M | 548.40%4.06M | 162.10%56M | -31.74%11.65M | -88.02%1.86M | -45.07%625.55K |
Cash received relating to other operating activities | -4.20%253.86M | 122.68%166.61M | 19.56%639.5M | -1.94%519.34M | -17.21%264.98M | -61.99%74.82M | -38.93%534.88M | -38.63%529.61M | -37.25%320.06M | -45.74%196.82M |
Cash inflows from operating activities | 19.04%22.78B | 23.20%10.13B | 6.11%40.64B | 3.50%29.2B | -2.28%19.14B | -8.20%8.22B | 3.20%38.3B | 3.59%28.22B | 9.82%19.58B | 11.51%8.95B |
Goods services cash paid | 13.47%14.32B | 24.12%7.27B | 3.27%26.42B | 2.70%19.1B | -0.35%12.62B | -4.40%5.86B | 9.19%25.58B | 7.64%18.6B | 14.65%12.67B | 17.85%6.13B |
Staff behalf paid | 8.66%1.74B | 17.49%845.67M | 18.30%3.13B | 18.71%2.16B | 20.87%1.6B | 10.11%719.76M | 15.27%2.64B | 12.29%1.82B | 16.16%1.32B | 12.81%653.69M |
All taxes paid | -23.55%1.4B | 27.73%609.7M | 92.14%3.07B | 50.84%2.31B | 78.39%1.82B | 4.46%477.34M | -27.04%1.6B | -14.70%1.53B | -27.86%1.02B | 0.78%456.96M |
Cash paid relating to other operating activities | 17.74%3.3B | 15.54%1.65B | 6.38%5.65B | 3.66%4.31B | -0.93%2.8B | 0.84%1.43B | -8.36%5.31B | -10.40%4.16B | -4.70%2.83B | -10.43%1.41B |
Cash outflows from operating activities | 10.11%20.76B | 22.32%10.37B | 8.91%38.26B | 6.79%27.88B | 5.64%18.85B | -1.98%8.48B | 4.24%35.13B | 3.05%26.11B | 7.65%17.84B | 10.77%8.65B |
Net cash flows from operating activities | 611.29%2.02B | 5.55%-246.15M | -24.86%2.38B | -37.31%1.32B | -83.65%284.23M | -186.20%-260.6M | -7.08%3.17B | 10.73%2.11B | 38.47%1.74B | 38.18%302.31M |
Investing cash flow | ||||||||||
Cash received from disposal of investments | ---- | ---- | ---- | ---- | ---- | ---- | 9,238,138,075.00%92.38M | --20.43M | ---- | ---- |
Cash received from returns on investments | 8,400.00%76.5M | ---- | 129.47%100.33M | -78.98%900K | -78.98%900K | ---- | 4,757.93%43.72M | 375.74%4.28M | 375.74%4.28M | ---- |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -34.43%5.34M | -89.64%149.2K | -80.50%15.43M | 574.95%13.56M | 1,896.09%8.14M | 2,751.19%1.44M | -78.82%79.16M | -99.42%2.01M | -99.88%407.74K | -99.99%50.5K |
Cash received relating to other investing activities | --148.46M | --44.31M | -83.91%5.88M | ---- | --0 | ---- | 232.92%36.52M | --29.6M | --4.79M | ---- |
Cash inflows from investing activities | 2,447.92%230.3M | 2,987.72%44.46M | -51.69%121.64M | -74.32%14.46M | -4.63%9.04M | 2,751.19%1.44M | -34.72%251.79M | -83.92%56.33M | -97.28%9.48M | -99.99%50.5K |
Cash paid to acquire fixed assets intangible assets and other long-term assets | -1.04%597.64M | 106.11%398.08M | 45.68%1.19B | 55.34%838.16M | 49.80%603.91M | -36.18%193.14M | -44.39%819.1M | -37.61%539.57M | -22.79%403.14M | 13.34%302.65M |
Cash paid to acquire investments | 79.57%52.79M | 76.17%51.79M | 244.52%848.91M | 608.76%855.52M | -75.64%29.4M | -72.19%29.4M | -61.41%246.4M | 71.13%120.71M | 71.13%120.71M | 5.71%105.71M |
Net cash paid to acquire subsidiaries and other business units | -52.00%130.06M | -87.80%34.64M | -47.98%411.91M | -47.91%404.62M | -64.19%270.95M | --284.03M | --791.86M | 131.88%776.79M | 481.96%756.55M | ---- |
Impawned loan net increase | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
Cash paid relating to other investing activities | -72.50%27.5M | ---- | -72.93%103.18M | 282.73%100M | 282.73%100M | 27.10%100M | 2,861.40%381.11M | --26.13M | --26.13M | --78.68M |
Cash outflows from investing activities | -19.54%807.99M | -20.12%484.52M | 14.24%2.56B | 50.24%2.2B | -23.13%1B | 24.55%606.57M | 5.37%2.24B | 15.18%1.46B | 80.78%1.31B | 32.70%487.03M |
Net cash flows from investing activities | 41.95%-577.69M | 27.28%-440.06M | -22.60%-2.44B | -55.23%-2.18B | 23.27%-995.22M | -24.26%-605.13M | -14.27%-1.99B | -52.91%-1.41B | -246.80%-1.3B | -2,206.61%-486.98M |
Financing cash flow | ||||||||||
Cash received from capital contributions | ---- | ---- | 3,392.90%174.65M | --30M | --30M | --30M | --5M | ---- | ---- | ---- |
-Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | 1,300.00%70M | --30M | --30M | --30M | --5M | ---- | ---- | ---- |
Cash from borrowing | -21.88%2.15B | 27.81%907.12M | 122.26%4.69B | 95.55%3.63B | 93.56%2.75B | -16.76%709.75M | -3.86%2.11B | -9.30%1.85B | -15.50%1.42B | 24.48%852.69M |
Cash received relating to other financing activities | 84.28%457.4M | -46.14%59.22M | 90.82%284.92M | 66.15%598.14M | --248.21M | --109.95M | 811.80%149.32M | 5.88%360M | ---- | ---- |
Cash inflows from financing activities | -13.95%2.61B | 13.73%966.34M | 127.41%5.15B | 92.12%4.25B | 113.14%3.03B | -0.35%849.7M | 2.41%2.26B | -7.13%2.21B | -29.71%1.42B | 24.48%852.69M |
Borrowing repayment | 19.27%2.56B | 102.72%1.65B | 86.85%4.29B | 67.60%3.14B | 63.75%2.14B | 14.78%815.27M | 1.69%2.3B | -13.27%1.87B | -29.24%1.31B | 32.32%710.29M |
Dividend interest payment | 5.62%618.61M | 69.17%64.85M | 25.02%578.86M | 25.75%627.88M | 23.88%585.72M | 32.45%38.34M | -29.38%463.03M | -18.48%499.32M | -21.87%472.83M | -15.92%28.95M |
-Including:Cash payments for dividends or profit to minority shareholders | 580.00%13.33M | 580.00%13.33M | -18.96%2.37M | --1.96M | --1.96M | --1.96M | -96.75%2.92M | ---- | ---- | ---- |
Cash payments relating to other financing activities | 1,620.45%356.28M | 5,828.93%98.18M | 39.32%379.53M | 63.75%598.79M | 281.79%20.71M | 534.43%1.66M | 1,090.71%272.41M | 2.34%365.68M | -98.24%5.42M | -90.66%261K |
Cash outflows from financing activities | 28.42%3.53B | 112.30%1.82B | 73.13%5.25B | 59.46%4.37B | 53.86%2.75B | 15.66%855.26M | 3.24%3.03B | -12.51%2.74B | -35.34%1.79B | 28.83%739.5M |
Net cash flows from financing activities | -433.51%-926.49M | -15,173.65%-849.41M | 87.01%-99.71M | 78.15%-114.87M | 175.72%277.8M | -104.91%-5.56M | -5.75%-767.45M | 29.66%-525.62M | 50.64%-366.91M | 2.00%113.2M |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | 134.02%8.95M | -58.11%4.53M | -237.45%-9.77M | 1,378.53%17.69M | -6,106.56%-26.31M | 478.71%10.81M | 133.16%7.11M | -130.78%-1.38M | -101.04%-423.91K | -139.79%-2.85M |
Net increase in cash and cash equivalents | 214.59%526.52M | -77.93%-1.53B | -138.61%-163.23M | -658.41%-960.75M | -719.79%-459.5M | -1,057.74%-860.49M | -54.33%422.73M | -28.02%172.05M | -58.61%74.14M | -123.53%-74.32M |
Add:Begin period cash and cash equivalents | -4.56%3.42B | -4.56%3.42B | 13.39%3.58B | 13.39%3.58B | 13.39%3.58B | 13.39%3.58B | 41.48%3.16B | 41.48%3.16B | 41.48%3.16B | 41.48%3.16B |
End period cash equivalent | 26.37%3.94B | -30.66%1.89B | -4.56%3.42B | -21.33%2.62B | -3.43%3.12B | -11.79%2.72B | 13.39%3.58B | 34.75%3.33B | 34.04%3.23B | 21.02%3.08B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
Auditor | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.